News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yüksel Ürün: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers
Yüksel Ürün/X
Apr 8, 2025, 03:09

Yüksel Ürün: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on X:

“TIL therapy + pembrolizumab (SEL-TIL + P) shows 23.5% response in mismatch repair–proficient GI cancers – where immunotherapy usually fails.

Neoantigen recognition may be the key.”

“Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial”

Authors:Frank J. Lowery et al.

Yüksel Ürün

Aaron J. Dinerman Aarushi Bhasin Abraham A. Hakim Alakesh Bera Alexandra M. Gustafson Billel Gasmi cancer Chuong D. Hoang Courtney D. Seavey Frank J. Lowery Hyunmi K. Halas Ian S. Goldlust James C. Yang Jared J. Gartner Jonathan M. Hernandez Juliette G. Rault-Wang Kyle J. Hitscherich Lior Levy Lisa M. Kenney Lori S. McIntyre Maria R. Parkhurst Mei Li M. Kwong Michelle M. Langhan Nicholas D. Klemen Nivedita M. Ratnam OncoDaily Oncology Paul F. Robbins Satyajit Ray Sivasish Sindiri Sri Krishna Stephanie L. Goff Steven A. Rosenberg Thomas E. Shelton Todd D. Prickett Victoria Dulemba Yüksel Ürün
Special Coverage
Positive
Aug 22, 2025, 04:59
Ammira Al-Shabeeb First Newborn Genome Screening Program in the Middle East
Voices
Aug 22, 2025, 04:56
Dario Trapani Highlights the Power of Narrative and Self-Inquiry in Oncology Practice
Positive
Aug 22, 2025, 04:41
Courtney Bugler Marks Two Years at ZERO with Milestones in Mission-Driven Transformation
Voices
Aug 22, 2025, 04:37
Christopher Steer Highlights Importance of Geriatric Assessment in Older Cancer Patients
Science
Aug 22, 2025, 04:34
Tanja Obradovic Tracks Progress of HARMONi-3 and HARMONi-7 Trials in Advanced NSCLC
Science
Aug 22, 2025, 04:29
Sourat Darabi Highlights Whole Exome vs Transcriptome Sequencing in Melanoma and Thyroid Cancers
Drugs
Aug 22, 2025, 04:27
Cemiplimab (Libtayo): A Patient Guide for 2025 to Treatment, Side Effects, Dosage, and Research
Voices
Aug 22, 2025, 04:22
UICC Highlights Cancer Care Systems That Extend Beyond Hospital Walls
Voices
Aug 22, 2025, 04:19
Juan W Valle: Funding Opportunity for Early-Career Researchers
Health Policy
Aug 22, 2025, 03:03
Guiding Families Through Childhood Cancer - The Dorcas Cancer Foundation
Voices
Aug 22, 2025, 02:57
Khalid El Bairi: How to Critically Appraise Randomized Controlled Trials
Career Updates
Aug 22, 2025, 02:54
Ajlan Al Zaki: New Beginnings at Cleveland Clinic Abu Dhabi